Download Files:
(±)13(14)-EpDPA
SKU
HY-130419-25 ug (290.28 μM * 250 μL in Ethanol)
Category Reference compound
Tags Neurological Disease; Cardiovascular Disease, Others
$180
Only 1000 item(s) left in stock.
Products Details
Product Description
– (±)13(14)-EpDPA (13,14-EpDPE) is the product of the reaction of cytochrome P-450 epoxygenase with Docosahexaenoic Acid (DHA).(±)13(14)-EpDPA has antihyperalgesic and vasorelaxative activities[1].
Web ID
– HY-130419
Storage Temperature
– Solution, -20°C, 2 years
Shipping
– Blue Ice
Molecular Formula
– C22H32O3
References
– [1]Christophe Morisseau, et al. Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids. J Lipid Res. 2010 Dec;51(12):3481-90.
CAS Number
– 895127-64-7
Molecular Weight
– 344.49
Compound Purity
– 95.0
SMILES
– O=C(O)CC/C=CC/C=CC/C=CCC1OC1C/C=CC/C=CCC
Clinical Information
– No Development Reported
Research Area
– Neurological Disease; Cardiovascular Disease
Target
– Others
Pathway
– Others
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.